Data as of Apr 17
| -0.02 / -1.39%|
The 2 analysts offering 12-month price forecasts for PharmAthene Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +181.69% increase from the last price of 1.42.
The current consensus among 2 polled investment analysts is to Buy stock in PharmAthene Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.